Laboratory Medicine ›› 2024, Vol. 39 ›› Issue (7): 640-644.DOI: 10.3969/j.issn.1673-8640.2024.07.004
Previous Articles Next Articles
YUAN Yongcheng, LIU Shangjun
Received:
2023-08-12
Revised:
2024-03-07
Online:
2024-07-30
Published:
2024-07-31
CLC Number:
YUAN Yongcheng, LIU Shangjun. Roles of C-reactive protein/albumin ratio and neutrophil/lymphocyte ratio in predicting obstructive sleep apnea hypopnea syndrome with hypertension[J]. Laboratory Medicine, 2024, 39(7): 640-644.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2024.07.004
组别 | 例数 | 年龄/岁 | 性别 | BMI/ | 心率/(次·min-1) | 呼吸/(次·min-1) | |
---|---|---|---|---|---|---|---|
男/[例(%)] | 女/[例(%)] | (kg·m-2) | |||||
合并高血压组 | 81 | 58.06±13.43 | 49(60.49) | 32(39.51) | 27.10±2.10 | 74.87±10.92 | 19.54±2.43 |
单纯OSAHS组 | 39 | 63.04±16.08 | 24(61.54) | 15(38.46) | 25.46±1.53 | 73.62±8.75 | 18.13±2.38 |
统计值 | 0.81 | 0.012 | 4.349 | 0.353 | 1.521 | ||
P值 | 0.418 | 0.913 | <0.001 | 0.726 | 0.135 | ||
组别 | 基础疾病 | 入院时血压 | |||||
糖尿病/ | 冠心病/ | COPD/ | 高脂血症/ | 收缩压/kPa | 舒张压/kPa | ||
[例(%)] | [例(%)] | [例(%)] | [例(%)] | ||||
合并高血压组 | 19(23.46) | 25(30.86) | 10(12.35) | 23(28.40) | 16.2(15.0,17.4) | 9.8(9.3,11.3) | |
单纯OSAHS组 | 3(7.69) | 13(33.33) | 3(7.69) | 4(10.26) | 16.4(15.2,17.6) | 9.7(7.0,11.2) | |
统计值 | 4.37 | 0.074 | 0.59 | 4.967 | 0.271 | 0.298 | |
P值 | 0.037 | 0.785 | 0.442 | 0.026 | 0.641 | 0.603 | |
组别 | 饮酒史/ | 吸烟史/ | NLR | CAR | OSAHS病情 | ||
[例(%)] | [例(%)] | 轻度/[例(%)] | 中度/[例(%)] | 重度/[例(%)] | |||
合并高血压组 | 32(39.51) | 28(34.57) | 7.72±1.89 | 3.14±0.73 | 15(18.52) | 49(60.49) | 17(20.99) |
单纯OSAHS组 | 12(30.77) | 13(33.33) | 5.25±1.12 | 2.37±0.64 | 19(48.72) | 15(38.46) | 5(12.82) |
统计值 | 0.865 | 0.018 | 5.008 | 3.03 | 2.98 | ||
P值 | 0.352 | 0.894 | <0.001 | 0.004 | 0.003 |
组别 | 例数 | 年龄/岁 | 性别 | BMI/ | 心率/(次·min-1) | 呼吸/(次·min-1) | |
---|---|---|---|---|---|---|---|
男/[例(%)] | 女/[例(%)] | (kg·m-2) | |||||
合并高血压组 | 81 | 58.06±13.43 | 49(60.49) | 32(39.51) | 27.10±2.10 | 74.87±10.92 | 19.54±2.43 |
单纯OSAHS组 | 39 | 63.04±16.08 | 24(61.54) | 15(38.46) | 25.46±1.53 | 73.62±8.75 | 18.13±2.38 |
统计值 | 0.81 | 0.012 | 4.349 | 0.353 | 1.521 | ||
P值 | 0.418 | 0.913 | <0.001 | 0.726 | 0.135 | ||
组别 | 基础疾病 | 入院时血压 | |||||
糖尿病/ | 冠心病/ | COPD/ | 高脂血症/ | 收缩压/kPa | 舒张压/kPa | ||
[例(%)] | [例(%)] | [例(%)] | [例(%)] | ||||
合并高血压组 | 19(23.46) | 25(30.86) | 10(12.35) | 23(28.40) | 16.2(15.0,17.4) | 9.8(9.3,11.3) | |
单纯OSAHS组 | 3(7.69) | 13(33.33) | 3(7.69) | 4(10.26) | 16.4(15.2,17.6) | 9.7(7.0,11.2) | |
统计值 | 4.37 | 0.074 | 0.59 | 4.967 | 0.271 | 0.298 | |
P值 | 0.037 | 0.785 | 0.442 | 0.026 | 0.641 | 0.603 | |
组别 | 饮酒史/ | 吸烟史/ | NLR | CAR | OSAHS病情 | ||
[例(%)] | [例(%)] | 轻度/[例(%)] | 中度/[例(%)] | 重度/[例(%)] | |||
合并高血压组 | 32(39.51) | 28(34.57) | 7.72±1.89 | 3.14±0.73 | 15(18.52) | 49(60.49) | 17(20.99) |
单纯OSAHS组 | 12(30.77) | 13(33.33) | 5.25±1.12 | 2.37±0.64 | 19(48.72) | 15(38.46) | 5(12.82) |
统计值 | 0.865 | 0.018 | 5.008 | 3.03 | 2.98 | ||
P值 | 0.352 | 0.894 | <0.001 | 0.004 | 0.003 |
高血压分级 | 例数 | NLR | CAR |
---|---|---|---|
1级 | 26 | 6.54±1.31 | 2.84±0.41 |
2级 | 38 | 7.96±1.27 | 3.16±0.48 |
3级 | 17 | 8.99±1.49 | 3.55±0.45 |
F值 | 18.585 | 12.732 | |
P值 | <0.001 | <0.001 |
高血压分级 | 例数 | NLR | CAR |
---|---|---|---|
1级 | 26 | 6.54±1.31 | 2.84±0.41 |
2级 | 38 | 7.96±1.27 | 3.16±0.48 |
3级 | 17 | 8.99±1.49 | 3.55±0.45 |
F值 | 18.585 | 12.732 | |
P值 | <0.001 | <0.001 |
项目 | β值 | 标准误 | Wald值 | P值 | OR①值(95%CI②) |
---|---|---|---|---|---|
BMI | 0.832 | 0.319 | 6.802 | 0.012 | 2.298(1.230~4.294) |
合并糖尿病 | 0.732 | 0.291 | 6.328 | 0.032 | 2.079(1.175~3.678) |
合并高脂血症 | 0.810 | 0.362 | 5.007 | 0.019 | 2.248(1.106~4.570) |
中度和重度OSAHS | 0.582 | 0.292 | 3.973 | 0.028 | 1.790(1.010~3.172) |
NLR | 1.731 | 0.395 | 19.204 | 0.000 | 5.646(2.603~12.246) |
CAR | 1.029 | 0.372 | 7.651 | 0.002 | 2.798(1.350~5.802) |
项目 | β值 | 标准误 | Wald值 | P值 | OR①值(95%CI②) |
---|---|---|---|---|---|
BMI | 0.832 | 0.319 | 6.802 | 0.012 | 2.298(1.230~4.294) |
合并糖尿病 | 0.732 | 0.291 | 6.328 | 0.032 | 2.079(1.175~3.678) |
合并高脂血症 | 0.810 | 0.362 | 5.007 | 0.019 | 2.248(1.106~4.570) |
中度和重度OSAHS | 0.582 | 0.292 | 3.973 | 0.028 | 1.790(1.010~3.172) |
NLR | 1.731 | 0.395 | 19.204 | 0.000 | 5.646(2.603~12.246) |
CAR | 1.029 | 0.372 | 7.651 | 0.002 | 2.798(1.350~5.802) |
项目 | AUC(95%CI) | 最佳临界值 | 敏感性/% | 特异性/% | Youden指数 |
---|---|---|---|---|---|
CAR | 0.696(0.560~0.773) | 1.44 | 80.25 | 71.79 | 0.520 |
NLR | 0.654(0.528~0.739) | 5.64 | 79.01 | 64.10 | 0.431 |
CAR+NLR | 0.802(0.721~0.893) | 82.72 | 56.41 | 0.391 | |
联合预测模型 | 0.845(0.737~0.916) | 0.673 | 87.65 | 76.92 | 0.646 |
项目 | AUC(95%CI) | 最佳临界值 | 敏感性/% | 特异性/% | Youden指数 |
---|---|---|---|---|---|
CAR | 0.696(0.560~0.773) | 1.44 | 80.25 | 71.79 | 0.520 |
NLR | 0.654(0.528~0.739) | 5.64 | 79.01 | 64.10 | 0.431 |
CAR+NLR | 0.802(0.721~0.893) | 82.72 | 56.41 | 0.391 | |
联合预测模型 | 0.845(0.737~0.916) | 0.673 | 87.65 | 76.92 | 0.646 |
[1] | 王云, 何燕, 刘师节, 等. 阻塞性睡眠呼吸暂停低通气综合征与糖脂代谢紊乱的机制研究进展[J]. 中国全科医学, 2022, 25(2): 243-247. |
[2] | JEHAN S, ZIZI F, PANDI-PERUMAL S R, et al. Obstructive sleep apnea,hypertension,resistant hypertension and cardiovascular disease[J]. Sleep Med Disord, 2020, 4(3):67-76. |
[3] | VAN RYSWYK E, MUKHERJEE S, CHAI-COETZER C L, et al. Sleep disorders,including sleep apnea and hypertension[J]. Am J Hypertens, 2018, 31(8):857-864. |
[4] | 李艳华, 袁开芬, 曹丽娇, 等. 阻塞性睡眠呼吸暂停低通气综合征合并慢性阻塞性肺疾病患者的心肺功能、缺氧程度及炎症因子变化的临床意义[J]. 中国呼吸与危重监护杂志, 2022, 21(9):629-635. |
[5] | GRAESER M, FEUERHAKE F, GLUZ O, et al. Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial[J]. J Immunother Cancer, 2021, 9(5):e002198. |
[6] | VAN DER TOUW T, ANDRONICOS N M, SMART N. Is C-reactive protein elevated in obstructive sleep apnea?A systematic review and meta-analysis[J]. Biomarkers, 2019, 24(5):429-435. |
[7] |
ÇALIK A N, İNAN D, KARATAŞ M B, et al. The association of preprocedural C-reactive protein/albumin ratio with in-stent restenosis in patients undergoing iliac artery stenting[J]. J Cardiovasc Thorac Res, 2020, 12(3):179-184.
DOI PMID |
[8] | 阻塞性睡眠呼吸暂停低通气综合征诊治指南(基层版)写作. 阻塞性睡眠呼吸暂停低通气综合征诊治指南(基层版)[J]. 中华全科医师杂志, 2015, 14(7):509-515. |
[9] | 《中国高血压防治指南》修订委员会. 中国高血压防治指南2018年修订版[J]. 心脑血管病防治, 2019, 19(1):1-44. |
[10] | 李南方, 王磊, 周克明, 等. 新疆维吾尔自治区人民医院住院高血压患者病因构成特点[J]. 中华心血管病杂志, 2007, 35(9):865-868. |
[11] | AYYASWAMY S, SHI H, ZHANG B, et al. Obstructive sleep apnea-induced hypertension is associated with increased gut and neuroinflammation[J]. J Am Heart Assoc, 2023, 12(11):e029218. |
[12] | 杨贝贝, 蒋军广, 史江, 等. 阻塞性睡眠呼吸暂停低通气综合征患者昼夜心室复极参数变化研究[J]. 中国全科医学, 2022, 25(2):175-179. |
[13] | IMANI M M, SADEGHI M, KHAZAIE H, et al. Evaluation of serum and plasma interleukin-6 levels in obstructive sleep apnea syndrome:a meta-analysis and meta-regression[J]. Front Immunol, 2020, 11:1343. |
[14] |
ZAMARRÓN C, GARCÍA PAZ V, MORETE E, et al. Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences[J]. Int J Chron Obstruct Pulmon Dis, 2008, 3(4):671-682.
DOI PMID |
[15] | QUAN X Q, JI H Y, JIANG J, et al. Prognostic utility of the combination of platelet count with neutrophil-to-lymphocyte ratio in aged patients with acute myocardial infarction undergoing percutaneous coronary intervention[J]. Emerg Med Int, 2021, 2021:4023472. |
[16] |
DINIZ L R, DE LIMA S G, DE AMORIM GARCIA J M, et al. Neutrophil to lymphocyte ratio as a prognostic predictor in older people with acute coronary syndrome[J]. Angiology, 2019, 70(3):264-271.
DOI PMID |
[17] | BAJARI R, TAK S. Predictive prognostic value of neutrophil-lymphocytes ratio in acute coronary syndrome[J]. Indian Heart J, 2017, 69(Supp 1):S46-S50. |
[18] |
LIU X, ZHANG Q, WU H, et al. Blood neutrophil to lymphocyte ratio as a predictor of hypertension[J]. Am J Hypertens, 2015, 28(11):1339-1346.
DOI PMID |
[19] | HE L, FAN C, LI G. The relationship between serum C-reactive protein and senile hypertension[J]. BMC Cardiovasc Disord, 2022, 22(1):500. |
[20] | SAVOIA C, SCHIFFRIN E L. Inflammation in hypertension[J]. Curr Opin Nephrol Hypertens, 2006, 15(2):152-158. |
[21] | 高春, 尼珍, 王凯, 等. 西藏拉萨2型糖尿病患者合并高血压对血清白蛋白的影响[J]. 中日友好医院学报, 2022, 36(5):263-266. |
[22] | Rencuzogullari I, Karabağ Y, Çağdaş M, et al. Assessment of the relationship between preprocedural C-reactive protein/albumin ratio and stent restenosis in patients with ST-segment elevation myocardial infarction[J]. Rev Port Cardiol (Engl Ed), 2019, 38(4):269-277. |
[23] | Zengin Temel T, Satilmis D, Yavuz BG, et al. The Value of C-reactive Protein/Albumin Ratio in the Prediction of Contrast-Induced Nephropathy in Emergency Department Patients[J]. Cureus, 2023, 15(5): e39230. |
[24] | HIZLI O, CAYIR S, COLUK Y, et al. The novel indicators of moderate to severe sleep apnea:fibrinogen to albumin ratio vs. CRP to albumin ratio[J]. Eur Arch Otorhinolaryngol, 2021, 278(3):851-855. |
[25] | SAYLIK F, AKBULUT T, KAYA S. Can C-reactive protein to albumin ratio predict in-hospital death rate due to COVID-19 in patients with hypertension?[J]. Angiology, 2021, 72(10):947-952. |
[1] | ZHOU Ruiling, ZHANG Xinyu, REN Xiaoling, ZHANG Wen, FAN Changzheng, ZHANG Qiong. Relationship between uric acid/creatinine ratio and neutrophil/lymphocyte ratio and hypoxemia in patients with acute exacerbation of chronic obstructive pulmonary disease [J]. Laboratory Medicine, 2024, 39(5): 474-479. |
[2] | DENG Xu, ZHUANG Wenlong, XUE Hui, ZHU Shuqin, LI Ying. Relationship between neutrophil/lymphocyte ratio,fibrinogen and carotid intima-media thickness in type 2 diabetes mellitus patients [J]. Laboratory Medicine, 2023, 38(4): 368-372. |
[3] | SONG Yunxiao, TONG Wei, ZHANG Haichen, ZHANG Yinwang, BIAN Xiaobo, ZHANG Linlin, YUAN Wenhua, ZHAO Zhiyun, GE Wen, YAO Tianyue. Correlation of systemic inflammatory markers and fracture occurrence in elderly patients with osteoporosis [J]. Laboratory Medicine, 2022, 37(3): 235-239. |
[4] | WANG Shan, XU Minyi, WANG Wei, JIANG Mingming, LU Pei, XIONG Zhongbo, WANG Lei. Clinical value of MTHFR gene C677T polymorphism determination in patients with H-type hypertension [J]. Laboratory Medicine, 2022, 37(11): 1012-1016. |
[5] | ZHANG Yinwang, LIU Jinyu, SONG Yunxiao, GE Wen, ZHANG Linlin, YUAN Wenhua, ZHAO Zhiyun. Relationship between preoperative SII and postoperative infection in patients with open fracture after internal fixation [J]. Laboratory Medicine, 2022, 37(11): 1071-1074. |
[6] | HU Bing, LI Gai, ZHANG Huimin. Roles of serum interleukin-6 and D-dimer levels in predicting the risk of cerebral hemorrhage in patients with hypertension [J]. Laboratory Medicine, 2022, 37(1): 63-67. |
[7] | FAN Taohong, SONG Zhiming, AN Yuanyuan, LIU Luyang, DONG Fengjuan. Correlation between exercise blood pressure and VCAM-1,sICAM-1 and FMD in patients with essential hypertension [J]. Laboratory Medicine, 2021, 36(4): 404-407. |
[8] | WANG Bin. Correlation between neutrophil-to-lymphocyte ratio and short-term poor prognosis in patients with corona virus disease 2019 [J]. Laboratory Medicine, 2021, 36(3): 275-280. |
[9] | ZHU Chuanxin, ZHOU Yuping, HE Yan, ZHOU Qin. Diagnostic role of NLR,CRP,PCT,DD and NT-proBNP in severe corona virus disease 2019 [J]. Laboratory Medicine, 2021, 36(2): 190-193. |
[10] | ZHU Chuanxin, ZHOU Yuping, ZHOU Qin, ZHOU Guifeng. Early diagnosis value of NLR,PCT and CRP combined determination for COVID-19 [J]. Laboratory Medicine, 2021, 36(1): 53-56. |
[11] | YAN Yufei, JIN Yiming, LIU Mingli, DENG Xuemei, QIN Qin. Role of neutrophil/lymphocyte ratio in SARS-CoV-2 infection [J]. Laboratory Medicine, 2020, 35(7): 637-639. |
[12] | CHEN Shuzi, LIN Ping, LI Ping, JIN Weifeng, LI Zhenhua, GAO Qiong, CHENG Xunjia. Changes of inflammatory factors,CHE and Hcy levels in patients with Alzheimer's disease [J]. Laboratory Medicine, 2020, 35(3): 205-208. |
[13] | ZENG Ruihuang, WANG Xiaolin, ZENG Ye, CHEN Zhixi, YUAN Ning, QIN Changhong. Roles of CA125,NLR,PLR and hs-CRP combined determination for community-acquired pneumonia with pleural effusion based on datum mining model [J]. Laboratory Medicine, 2020, 35(11): 1103-1107. |
[14] | LI Bo, WANG Haiyu, LIU Yajie. Role of NGAL for the diagnosis of kidney injury in patients with essential hypertension [J]. Laboratory Medicine, 2019, 34(5): 390-393. |
[15] | WU Bing, YU Fang, ZHANG Yong, ZHOU Yuntao, SHI Lu, TIAN Wei. Role of plasma aldosterone to direct renin ratio in primary aldosteronism [J]. Laboratory Medicine, 2019, 34(2): 130-135. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||